SEC Form 4 · accession 0001437749-19-004616
NATIONAL HEALTHCARE CORP · NHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Paul Abernathy
Director
Period of report
Mar 8, 2019
Accepted (ET)
Mar 12, 2019 · 12:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001047335
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Shares of Common StockF1 | Mar 8, 2019 | M | 1,714 | $72.94 | A | 24,652 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock | $72.94 | Mar 8, 2019 | M | 1,714 | D | May 9, 2017 | May 8, 2022 | Common Stock | 7,500 | 5,786 | D |
| Option to Purchase Common Stock | $62.78 | holding | — | — | — | Jun 2, 2016 | Jun 1, 2021 | Common Stock | 5,508 | 5,508 | D |
| Option to Purchase Common Stock | $61.90 | holding | — | — | — | May 3, 2018 | May 2, 2023 | Common Stock | 7,500 | 7,500 | D |
Explanation of responses
- F1These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).